Clinical course and final outcome of asymptomatic children with ‘culture-confirmed’ drug-resistant tuberculosis in Durban, South Africa
| Clinical course/outcome | Number (%) N=43 |
|---|---|
| Management | |
| Length of follow-up in days; median (IQR) | 549 (259–722) |
| Minimum period of follow-up (days) | 109 |
| Change in weight | |
| Crossed centile line/s upwards | 21 (49) |
| Same centile line | 10 (23) |
| Crossed centile line/s downwards | 4 (9) |
| No follow-up weight recorded as lost to follow-up or died | 8 (19) |
| Outcome* | |
| Well | 34 (80) |
| Lost to follow-up | 7 (16) |
| Doing well at 365 days, subsequently lost to follow-up | 4 (9) |
| Started on MDR-TB treatment | 1 (2) |
| Died | 1 (2) |
*Outcome at final evaluation.
MDR-TB, multidrug-resistant tuberculosis.